Integrated network pharmacology and experimental validation to explore the potential pharmacological mechanism of Qihuang Granule and its main ingredients in regulating ferroptosis in AMD
机构:[1]Department of Ophthalmology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111DaDe Road, Guangzhou, Guangdong, 510120, China.大德路总院珠海院区眼科眼科广东省中医院[2]Department of Ophthalmology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.大德路总院珠海院区眼科眼科广东省中医院
This work was supported by the National Natural Science Foundation of
China (grant numbers: 81503618) and Special Research Project in Guangdong
Provincial Hospital of Chinese Medicine (No: YN2018M703).
第一作者机构:[1]Department of Ophthalmology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111DaDe Road, Guangzhou, Guangdong, 510120, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wang Lu,Zhang Canyang,Pang Long,et al.Integrated network pharmacology and experimental validation to explore the potential pharmacological mechanism of Qihuang Granule and its main ingredients in regulating ferroptosis in AMD[J].BMC COMPLEMENTARY MEDICINE AND THERAPIES.2023,23(1):doi:10.1186/s12906-023-04205-3.
APA:
Wang Lu,Zhang Canyang,Pang Long&Wang Yan.(2023).Integrated network pharmacology and experimental validation to explore the potential pharmacological mechanism of Qihuang Granule and its main ingredients in regulating ferroptosis in AMD.BMC COMPLEMENTARY MEDICINE AND THERAPIES,23,(1)
MLA:
Wang Lu,et al."Integrated network pharmacology and experimental validation to explore the potential pharmacological mechanism of Qihuang Granule and its main ingredients in regulating ferroptosis in AMD".BMC COMPLEMENTARY MEDICINE AND THERAPIES 23..1(2023)